Acquisition · Healthcare & Life Sciences
Redcliffe Labs acquires Megavision Diagnostics for ₹40 Cr
By Startup Enthusiast ·
- Date
- Company
- Redcliffe Labs
- What it does
- Omnichannel diagnostics platform
- Kind
- Acquisition
- Amount
- ₹40 Cr
What they do
Redcliffe Labs is an omnichannel diagnostics platform offering over 3,600 tests across India
What happened
It has acquired Pune-based Megavision Diagnostics Centre for ₹40 Cr ($4.14 Mn), expected to close in July 2026
Why it matters
The deal follows two smaller acquisitions and a divestiture of its fertility business earlier this year
The details
- Redcliffe Labs is acquiring Megavision Diagnostics Centre in a ₹40 Cr deal.
- Megavision is a Pune-based diagnostics chain founded in 1996 with two centres in Pimpri and Nigdi.
- It offers MRI, CT scans, sonography, ECG, and mammography services.
- Megavision's annual revenue is about ₹20 Cr.
- The transaction is expected to close later this month (July 2026).
- Redcliffe will retain Megavision's entire workforce.
- Weeks before this deal, Redcliffe acquired Prime Sonography and Diagnostic Center (Kota) for about ₹5 Cr and Sarvodaya Diagnostics (Ajmer) for about ₹10 Cr.
- Earlier in 2026, Redcliffe divested its fertility business Crysta IVF to Moon Care Pvt Ltd for about ₹100 Cr.
The bigger picture
- Redcliffe's revenue grew 12% to ₹470 Cr in FY26 from ₹418 Cr in FY25.
- Its EBITDA loss margin narrowed to -13% in FY26 from -24% in FY25.
- The company targets revenue of about ₹700 Cr in FY27, nearly 50% growth.
- Redcliffe has raised $115 Mn to date from investors including LeapFrog Investments and HealthQuad.
About the business
- Redcliffe Labs is an omnichannel diagnostics platform with over 3,600 pathology tests.
- It offers genetic and DNA-based screening for reproductive health, cancer, and wellness.
- The company operates in 70-80 cities across India.
- It has 80+ self-owned certified labs and 2,000+ collection centres.
- Home sample collection accounts for nearly half of its business.
- Redcliffe served more than 4.3 Mn customers in FY26, conducting 24 Mn diagnostic tests.
- 64% of its customer base comes from Tier I and II cities.
- It provides AI-enabled diagnostic reports, consultations, and diet plans through its mobile app.
What happens next
- Redcliffe targets revenue of about ₹700 Cr in FY27, nearly 50% year-on-year growth.
The deal
- Type
- acquisition
Founders
- Aditya Kandoi, Cofounder and CEO
- Dheeraj Jain, Cofounder and Chairman
Other articles talking about it
More on Redcliffe Labs
- Redcliffe Labs partners with Skyroot Aerospace for space diagnostics14 August 2026 · Partnership
- Redcliffe Labs acquires Megavision Diagnostics for ₹40 crore11 August 2026 · Acquisition · ₹40 crore
- Redcliffe Labs launches preventive healthcare campaign with Gambhir22 May 2026 · Launch
- Redcliffe Labs reappoints Gautam Gambhir as brand ambassador19 August 2025 · Partnership
- Redcliffe Labs reports 20% revenue growth in FY258 July 2025 · Results
- Redcliffe Labs launches women's health platform Femcliffe9 May 2025 · Launch
- Redcliffe Labs appoints Dr. Prashant Nag as COMO1 May 2025 · People
- Redcliffe Labs narrows losses in FY2410 December 2024 · Results
Same day
- Seeds Fincap wins Gold client protection certification20 July 2026 · News
- Cosmoserve's soft robotic capture system tested in orbit despite deployment glitch20 July 2026 · Launch
- Veriqus Group raises ₹387 crore from Norwest20 July 2026 · Funding · ₹387 crore
- Plazza raises $15M in Series A funding20 July 2026 · Funding · $15M
- LNGVTY raises Rs 5 crore seed round led by Rukam Capital20 July 2026 · Funding · Rs 5 crore
- The Divine Foods reaches 25 crore turnover20 July 2026 · Analysis